CHE is estimated to affect close to 5% of adults and can cause pain, itching, redness, blistering and swelling of the hands and wrists, among other symptoms, per Leo. “Given that we use our ...

preparing them to lead LEO Pharma through the next stage of the climb🏔 The past three years of our transformation journey have shown the tremendous potential of our organization, and we are ...

"Gilead and LEO Pharma link on programmes for inflammatory conditions" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has ...

LEO Pharma is developing a wearable device based on miniature sensors and plans to assess its clinical potential in dermatology drug development. The pharmaceutical company’s Boston-based R&D ...

according to the second phase of the survey sponsored by LEO Pharma Inc., a global leader in medical dermatology, and conducted by Ipsos. The survey, which includes responses from 100 doctors and ...

The EMA has started a review of Leo Pharma’s interleukin-13 inhibitor ... with Sanofi suggesting it could become a $10 billion brand at its peak. The drug’s mechanism of action simultaneously ...

To learn more about CHE, visit www.TalkCHE.com. LEO Pharma is a global leader in medical dermatology. We deliver innovative solutions for skin health, building on a century of experience with ...

As more and more businesses recognize the importance of a strong online presence, competition for digital space intensifies. According to Statista, worldwide marketing and advertising spending is ...

L-R: Ignasi Biosca, CEO of Reig Jofre, and Juan Fran Cuello de Oro, general manager of LEO Pharma Iberia LEO Pharma and Reig Jofre have entered into a partnership aimed at improving access to LEO’s ...

For cross-functional brand teams this presents a powerful chance to enhance both the strategic and tactical elements of brand plans. There is much excitement and activity in the pharma AI race, but we ...